Fukushima M, Nishil Y, Suzuki M, Suda T
Biochem J. 1978 Mar 15;170(3):495-502. doi: 10.1042/bj1700495.
The 25-hydroxylations of [(3)H]cholecalciferol and 1alpha-hydroxy[(3)H]cholecalciferol in perfused rat liver were compared. Results showed that about twice as much 1alpha(OH)D(3) (1alpha-hydroxycholecalciferol) was incorporated into the liver as cholecalciferol. 25-Hydroxy[(3)H]cholecalciferol and 1alpha-25-dihydroxy[(3)H]cholecalciferol were not incorporated significantly. Livers isolated from vitamin D-deficient rats formed the 25-hydroxy derivatives of cholecalciferol and 1alpha(OH)D(3) respectively linearly with time for at least 120min. The rate of 1alpha,25(OH)(2)D(3) (1alpha,25-dihydroxycholecalciferol) production increased exactly 10-fold on successive 10-fold increases in the dose of 1alpha(OH)D(3), suggesting that hepatic 25-hydroxylation of 1alpha(OH)D(3) is not under metabolic control. On the other hand, the rate of conversion of cholecalciferol into 25(OH)D(3) (25-hydroxycholecalciferol) did not increase linearly with increase in the amount of cholecalciferol in the perfusate. The 25-hydroxylation of cholecalciferol seemed to proceed at a similar rate to that of 1alpha(OH)D(3) at doses of less than 1nmol, but with doses of more than 2.5nmol, the conversion of cholecalciferol into 25(OH)D(3) became much less efficient, though the linear relation between the amounts of substrate and product was maintained. A reciprocal plot of data on the 25-hydroxylation of cholecalciferol gave two K(m) values of about 5.6nm and 1.0mum, whereas that for the 25-hydroxylation of 1alpha(OH)D(3) gave a single K(m) value of about 2.0mum. These results suggest that there are two modes of 25-hydroxylation of cholecalciferol in the liver, which seem to be closely related to the mechanism of control of 25(OH)D(3) production by the liver.
比较了灌注大鼠肝脏中[³H]胆钙化醇和1α-羟基[³H]胆钙化醇的25-羟化作用。结果表明,肝脏摄取的1α(OH)D₃(1α-羟胆钙化醇)约为胆钙化醇的两倍。25-羟基[³H]胆钙化醇和1α,25-二羟基[³H]胆钙化醇的摄取量不显著。从维生素D缺乏的大鼠分离出的肝脏,分别在至少120分钟内与时间呈线性关系形成胆钙化醇和1α(OH)D₃的25-羟基衍生物。随着1α(OH)D₃剂量连续10倍增加,1α,25(OH)₂D₃(1α,25-二羟胆钙化醇)的生成速率精确增加10倍,这表明肝脏中1α(OH)D₃的25-羟化不受代谢控制。另一方面,胆钙化醇转化为25(OH)D₃(25-羟胆钙化醇)的速率并不随灌注液中胆钙化醇量的增加而呈线性增加。在剂量小于1nmol时,胆钙化醇的25-羟化速率似乎与1α(OH)D₃的相似,但在剂量大于2.5nmol时,胆钙化醇转化为25(OH)D₃的效率变得低得多,尽管底物和产物量之间的线性关系得以维持。胆钙化醇25-羟化作用数据的双倒数图给出两个Kₘ值,约为5.6nm和1.0μm,而1α(OH)D₃的25-羟化作用给出单个Kₘ值约为2.0μm。这些结果表明,肝脏中胆钙化醇的25-羟化有两种模式,这似乎与肝脏控制25(OH)D₃生成的机制密切相关。